Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first481 to 500 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| VHL von Hippel-Lindau tumor suppressor | 7428 HGNC:12687 | 1 | 55 | 0 | 0 | 5,850 | 15,284 |
| PROC protein C, inactivator of coagulation factors Va and VIIIa | 5624 HGNC:9451 | 1 | 149 | 2 | 13 | 3,226 | 15,233 |
| CD2 CD2 molecule | 914 HGNC:1639 | 1 | 215 | 2 | 38 | 6,678 | 15,189 |
| PTPN11 protein tyrosine phosphatase non-receptor type 11 | 5781 HGNC:9644 | 1 | 52 | 1 | 2 | 7,408 | 15,170 |
| CA2 carbonic anhydrase 2 | 760 HGNC:1373 | 1 | 136 | 11 | 323 | 7,275 | 15,113 |
| BCL6 BCL6 transcription repressor | 604 HGNC:1001 | 1 | 85 | 0 | 0 | 5,951 | 15,021 |
| MRC1 mannose receptor C-type 1 | 4360 HGNC:7228 | 1 | 53 | 0 | 0 | 7,262 | 14,934 |
| CYP2C9 cytochrome P450 family 2 subfamily C member 9 | 1559 HGNC:2623 | 1 | 55 | 0 | 0 | 3,903 | 14,924 |
| CCN2 cellular communication network factor 2 | 1490 HGNC:2500 | 1 | 62 | 1 | 19 | 6,423 | 14,905 |
| STK11 serine/threonine kinase 11 | 6794 HGNC:11389 | 1 | 69 | 0 | 0 | 6,046 | 14,866 |
| GDNF glial cell derived neurotrophic factor | 2668 HGNC:4232 | 1 | 182 | 0 | 0 | 7,678 | 14,796 |
| LGALS3 galectin 3 | 3958 HGNC:6563 | 1 | 166 | 3 | 14 | 5,577 | 14,742 |
| IRS1 insulin receptor substrate 1 | 3667 HGNC:6125 | 1 | 117 | 1 | 1 | 7,008 | 14,719 |
| ERBB3 erb-b2 receptor tyrosine kinase 3 | 2065 HGNC:3431 | 1 | 279 | 18 | 190 | 5,986 | 14,691 |
| COMT catechol-O-methyltransferase | 1312 HGNC:2228 | 1 | 93 | 4 | 63 | 6,693 | 14,671 |
| EGR1 early growth response 1 | 1958 HGNC:3238 | 1 | 127 | 1 | 0 | 8,362 | 14,658 |
| S100B S100 calcium binding protein B | 6285 HGNC:10500 | 1 | 105 | 0 | 0 | 6,204 | 14,655 |
| NPM1 nucleophosmin 1 | 4869 HGNC:7910 | 1 | 104 | 2 | 134 | 5,449 | 14,642 |
| TARDBP TAR DNA binding protein | 23435 HGNC:11571 | 1 | 172 | 0 | 0 | 6,052 | 14,640 |
| CD24 CD24 molecule | 100133941 HGNC:1645 | 1 | 132 | 0 | 0 | 6,615 | 14,615 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=25
{
"data": {
"total": 193990,
"results": [
{
"id": "7428",
"title": "VHL: von Hippel-Lindau tumor suppressor",
"summary": "NCBI Gene 7428. 1 protein, 55 patents, 0 drugs, 0 trials, 5,850 NIH grants and 15,284 papers.",
"record": "/library/genes/7428",
"gene_id": 7428,
"symbol": "VHL",
"name": "von Hippel-Lindau tumor suppressor",
"hgnc_id": "HGNC:12687",
"counts": {
"proteins": 1,
"patents": 55,
"drugs": 0,
"trials": 0,
"grants": 5850,
"papers": 15284
}
},
{
"id": "5624",
"title": "PROC: protein C, inactivator of coagulation factors Va and VIIIa",
"summary": "NCBI Gene 5624. 1 protein, 149 patents, 2 drugs, 13 trials, 3,226 NIH grants and 15,233 papers.",
"record": "/library/genes/5624",
"gene_id": 5624,
"symbol": "PROC",
"name": "protein C, inactivator of coagulation factors Va and VIIIa",
"hgnc_id": "HGNC:9451",
"counts": {
"proteins": 1,
"patents": 149,
"drugs": 2,
"trials": 13,
"grants": 3226,
"papers": 15233
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=26",
"request_id": "l2zoFTzCk58BpGnN"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant